Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor GRHL3 via down regualtion of its target gene, 18/April/2014, 22.34

Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor p53 homologue TAp63 via down regualtion of its target gene, 18/April/2014, 22.32
April 18, 2014
Oxidative stress: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression SOD3 via down regulation of its target gene, 18/April/2014, 22.35
April 18, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, increases the expression of tumor suppressor GRHL3  via  down regualtion of  its target gene, 18/April/2014, 22.34,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.